
浏览全部资源
扫码关注微信
中国中医科学院广安门医院南区 内分泌科, 北京, 102618
刘素珀, E-mail: 745262096@qq.com
网络出版日期:2024-11-06,
收稿日期:2024-09-20,
移动端阅览
马娟娟, 刘素珀, 周松飞, 等. 穴位埋线联合中医无饥饿禁食疗法序贯治疗3例肥胖型2型糖尿病患者的护理[DB/OL].中西医结合临床案例库, 2024.
MA Juanjuan, LIU Supo, ZHOU Songfei, et al. Nursing care of 3 obese patients with type 2 diabetes treated by acupoint catgut embedding combined with traditional Chinese medicine non hunger fast. [DB/OL].Clinical Archives of Integrative Medicine, 2024.
马娟娟, 刘素珀, 周松飞, 等. 穴位埋线联合中医无饥饿禁食疗法序贯治疗3例肥胖型2型糖尿病患者的护理[DB/OL].中西医结合临床案例库, 2024. DOI: 10.12209/CAIM202409200001.
MA Juanjuan, LIU Supo, ZHOU Songfei, et al. Nursing care of 3 obese patients with type 2 diabetes treated by acupoint catgut embedding combined with traditional Chinese medicine non hunger fast. [DB/OL].Clinical Archives of Integrative Medicine, 2024. DOI: 10.12209/CAIM202409200001.
本文总结3例穴位埋线联合中医无饥饿禁食疗法序贯治疗肥胖型2型糖尿病(T2DM)患者的护理病例报告。基于中医辨证施护理论,采用穴位埋线联合中医无饥饿禁食疗法,配合常规护理措施,明显改善患者血糖情况及体质指标,且该治疗方法安全、经济,患者易于接受。
This paper summarized the nursing case report of 3 cases of obese type 2 diabetes (T2DM) treated by acupoint catgut embedding combined with Chinese medicine non hunger fasting therapy. Based on the theory of traditional Chinese medicine syndrome differentiation and nursing, the combination of acupoint embedding and traditional Chinese medicine hunger free fasting therapy, combined with routine nursing measures, significantly improves the patient's blood sugar level and physical indicators. This treatment method is safe, economical, and easy for patients to accept.
穴位埋线中医无饥饿禁食疗法肥胖型2型糖尿病序贯治疗
acupoint embedding threadTraditional Chinese Medicine Non Hunger Fasting TherapyObese typeType 2 diabetesSequential therapy
李若涵, 唐彦, 王睿韬, 等. 医联体模式下药师介入2型糖尿病管理效果评价[J]. 临床药物治疗杂志, 2023, 21(4): 29-33.
LI R H, TANG Y, WANG R T, et al. Evaluation of the effect of pharmacists' intervention on management of type 2 diabetes under the medical consortium model[J]. Clin Med J, 2023, 21(4): 29-33.(in Chinese)
高晶晶, 高艳虹. 早发2型糖尿病流行病学、临床特征及病因机制的研究进展[J]. 内科理论与实践, 2022, 17(4): 344-348.
GAO J J, GAO Y H. The pathogenesis of early-onset type 2 diabetes: research update[J]. J Intern Med Concepts Pract, 2022, 17(4): 344-348.(in Chinese)
龚彤, 陈国芳, 狄红杰, 等. 短期极低热量限制对超重/肥胖2型糖尿病患者肠道菌群的影响[J]. 中华内分泌代谢杂志, 2022, 38(2): 93-99.
GONG T, CHEN G F, DI H J, et al. Effects of short-term very low-calorie restriction on gut microbiota in overweight/obese patients with type 2 diabetes[J]. Chin J Endocrinol Metab, 2022, 38(2): 93-99.(in Chinese)
丁露, 周丽媛, 肖新华. 间歇性禁食管理2型糖尿病: 机遇与挑战并存[J]. 中华糖尿病杂志, 2022, 14(1): 9-11.
DING L, ZHOU L Y, XIAO X H. Intermittent fasting for type 2 diabetes mellitus: new opportunity and challenge[J]. Chin J Diabetes Mellit, 2022, 14(1): 9-11.(in Chinese)
王露露, 刘鲁豫, 谢秀春. 2型糖尿病合并肥胖患者的糖脂代谢状况及中医证素临床分析[J]. 海南医学, 2023, 34(10): 1402-1405.
WANG L L, LIU L Y, XIE X C. Clinical analysis of glucose and lipid metabolism and TCM syndrome elements in patients with type 2 diabetes mellitus complicated with obesity[J]. Hainan Med J, 2023, 34(10): 1402-1405.(in Chinese)
陈艳, 刘慧, 张哲, 等. 穴位埋线治疗肥胖症的研究进展[J]. 中医临床研究, 2021, 13(4): 145-148.
CHEN Y, LIU H, ZHANG Z, et al. A review on treating obesity by catgut implantation at acupoint[J]. Clin J Chin Med, 2021, 13(4): 145-148.(in Chinese)
耿健, 许雍荣, 张宇鑫, 等. 王维峰运用穴位埋线治疗过敏性疾病经验[J]. 中国民间疗法, 2024, 32(17): 11-14.
GENG J, XU Y R, ZHANG Y X, et al. WANG Weifeng’s experience in treating allergic diseases by catgut-embedding therapy[J]. China’s Naturopathy, 2024, 32(17): 11-14.(in Chinese)
张汀滢, 刘桃丽, 胡建国, 等. 中医禁食疗法对超重/肥胖2型糖尿病患者的临床疗效[J]. 中山大学学报(医学科学版), 2022, 43(4): 613-620.
ZHANG T Y, LIU T L, HU J G, et al. Clinical effects of Chinese medicine fasting therapy in overweight/obese type 2 diabetes patients[J]. J Sun Yat Sen Univ Med Sci, 2022, 43(4): 613-620.(in Chinese)
巴涛, 王晓丽, 常向云. 间歇性禁食对减重和糖脂代谢作用的研究进展[J]. 中国全科医学, 2022, 25(1): 122-126.
BA T, WANG X L, CHANG X Y. Latest developments in the effects of intermittent fasting on weight loss and glycolipid metabolism[J]. Chin Gen Pract, 2022, 25(1): 122-126.(in Chinese)
GARBER A, HENRY R, RATNER R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial[J]. Lancet, 2009, 373(9662): 473-481.
李辉, 肖明中, 李恒飞, 等. 中医禁食疗法专家共识(征求意见稿)2019年第1版[J]. 中西医结合肝病杂志, 2019, 29(6): 577-580.
LI H, XIAO M Z, LI H F, et al. Traditional Chinese medicine fasting therapy expert consensus (draft for comment) the first edition of 2019[J]. Chin J Integr Tradit West Med Liver Dis, 2019, 29(6): 577-580.(in Chinese)
童楠, 陈惠, 童安荣, 等. 倪青教授治疗2型糖尿病合并肥胖临床经验总结[J]. 世界中医药, 2023, 18(22): 3254-3258.
TONG N, CHEN H, TONG A R, et al. Clinical experience of professor NI Qing in treating type 2 diabetes combined with obesity[J]. World Chin Med, 2023, 18(22): 3254-3258.(in Chinese)
谭艳丹, 刘峻熙, 赵溱, 等. 肥胖发展为二型糖尿病潜在机制的生物信息学研究[J]. 热带医学杂志, 2022, 22(3): 301-305, 448.
TAN Y D, LIU J X, ZHAO Z, et al. Bioinformatics studies on the potential mechanisms of obesity progression to type 2 diabetes mellitus[J]. J Trop Med, 2022, 22(3): 301-305, 448.(in Chinese)
于业波, 黄镇, 吴一波, 等. 2型糖尿病患者的用药依从性与生存质量的关系及自我效能的调节作用[J]. 中华疾病控制杂志, 2024, 28(2): 228-232, 240.
YU Y B, HUANG Z, WU Y B, et al. Self-efficacy as a moderator in relationship between medication adherence and quality of life among patients with type 2 diabetes[J]. Chin J Dis Contr Prev, 2024, 28(2): 228-232, 240.(in Chinese)
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621